Cargando…

Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional procedure that requires deep sedation or general anaesthesia. The purpose of this prospective observational study was to assess the feasibility and safety of deep sedation in ERCP to maintain spontaneous breathing...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vico, Pasquale, Biasucci, Daniele G., Aversano, Lucia, Polidoro, Roberto, Zingaro, Alessia, Millarelli, Francesca Romana, Del Vecchio Blanco, Giovanna, Paoluzi, Omero Alessandro, Troncone, Edoardo, Monteleone, Giovanni, Dauri, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401822/
https://www.ncbi.nlm.nih.gov/pubmed/37542218
http://dx.doi.org/10.1186/s12871-023-02218-6
_version_ 1785084748687736832
author De Vico, Pasquale
Biasucci, Daniele G.
Aversano, Lucia
Polidoro, Roberto
Zingaro, Alessia
Millarelli, Francesca Romana
Del Vecchio Blanco, Giovanna
Paoluzi, Omero Alessandro
Troncone, Edoardo
Monteleone, Giovanni
Dauri, Mario
author_facet De Vico, Pasquale
Biasucci, Daniele G.
Aversano, Lucia
Polidoro, Roberto
Zingaro, Alessia
Millarelli, Francesca Romana
Del Vecchio Blanco, Giovanna
Paoluzi, Omero Alessandro
Troncone, Edoardo
Monteleone, Giovanni
Dauri, Mario
author_sort De Vico, Pasquale
collection PubMed
description BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional procedure that requires deep sedation or general anaesthesia. The purpose of this prospective observational study was to assess the feasibility and safety of deep sedation in ERCP to maintain spontaneous breathing. METHODS: This is a single-centre observational prospective cohort study conducted in a tertiary referral university hospital. All consecutive patients who needed sedation or general anaesthesia for ERCP were included from January 2021 to June 2021. Deep sedation was achieved and maintained by continuous infusion of an association of propofol and remifentanil. The primary endpoint was to assess the prevalence of major anaesthesia-related complications, such as arrhythmias, hypotension, gas exchange dysfunction, and vomiting (safety endpoint). Secondary endpoints were: (a) to assess the prevalence of signs of an insufficient level of sedation, such as movement, cough, and hiccups (feasibility endpoint): (b) time needed to achieve the target level of sedation and for recovery from anaesthesia. In order to do so we collect the following parameters: peripheral oxygen saturation, fraction of inspired oxygen, noninvasive systemic blood pressure, heart rate, number of breaths per minute, neurological functions with the use of the bispectral index to determine depth of anaesthesia, and partially exhaustive CO(2) end pressure to continuously assess the ventilatory status. The collected data were analysed by several tests: Shapiro-Wilk, Student’s t, Tuckey post-hoc, Wilcoxon rank-sum and Kruskall-Wallis ran. Statistical analysis was performed using Stata/BE 17.0 (StataCorp LLC). RESULTS: 114 patients were enroled. Eight patients were excluded because they did not meet the inclusion criteria. We found that all patients were hemodynamically stable: intraoperative mean systolic blood pressure was 139,23 mmHg, mean arterial pressure was on average 106,66 mmHg, mean heart rate was 74,471 bpm. The mean time to achieve the target level of sedation was 63 s, while the mean time for the awakening after having stopped drug infusion was 92 s. CONCLUSIONS: During ERCP, deep sedation and analgesia using the association of propofol and remifentanil and maintaining spontaneous breathing are safe and feasible, allowing for a safe and quick recovery from anaesthesia.
format Online
Article
Text
id pubmed-10401822
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104018222023-08-05 Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study De Vico, Pasquale Biasucci, Daniele G. Aversano, Lucia Polidoro, Roberto Zingaro, Alessia Millarelli, Francesca Romana Del Vecchio Blanco, Giovanna Paoluzi, Omero Alessandro Troncone, Edoardo Monteleone, Giovanni Dauri, Mario BMC Anesthesiol Research BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional procedure that requires deep sedation or general anaesthesia. The purpose of this prospective observational study was to assess the feasibility and safety of deep sedation in ERCP to maintain spontaneous breathing. METHODS: This is a single-centre observational prospective cohort study conducted in a tertiary referral university hospital. All consecutive patients who needed sedation or general anaesthesia for ERCP were included from January 2021 to June 2021. Deep sedation was achieved and maintained by continuous infusion of an association of propofol and remifentanil. The primary endpoint was to assess the prevalence of major anaesthesia-related complications, such as arrhythmias, hypotension, gas exchange dysfunction, and vomiting (safety endpoint). Secondary endpoints were: (a) to assess the prevalence of signs of an insufficient level of sedation, such as movement, cough, and hiccups (feasibility endpoint): (b) time needed to achieve the target level of sedation and for recovery from anaesthesia. In order to do so we collect the following parameters: peripheral oxygen saturation, fraction of inspired oxygen, noninvasive systemic blood pressure, heart rate, number of breaths per minute, neurological functions with the use of the bispectral index to determine depth of anaesthesia, and partially exhaustive CO(2) end pressure to continuously assess the ventilatory status. The collected data were analysed by several tests: Shapiro-Wilk, Student’s t, Tuckey post-hoc, Wilcoxon rank-sum and Kruskall-Wallis ran. Statistical analysis was performed using Stata/BE 17.0 (StataCorp LLC). RESULTS: 114 patients were enroled. Eight patients were excluded because they did not meet the inclusion criteria. We found that all patients were hemodynamically stable: intraoperative mean systolic blood pressure was 139,23 mmHg, mean arterial pressure was on average 106,66 mmHg, mean heart rate was 74,471 bpm. The mean time to achieve the target level of sedation was 63 s, while the mean time for the awakening after having stopped drug infusion was 92 s. CONCLUSIONS: During ERCP, deep sedation and analgesia using the association of propofol and remifentanil and maintaining spontaneous breathing are safe and feasible, allowing for a safe and quick recovery from anaesthesia. BioMed Central 2023-08-04 /pmc/articles/PMC10401822/ /pubmed/37542218 http://dx.doi.org/10.1186/s12871-023-02218-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
De Vico, Pasquale
Biasucci, Daniele G.
Aversano, Lucia
Polidoro, Roberto
Zingaro, Alessia
Millarelli, Francesca Romana
Del Vecchio Blanco, Giovanna
Paoluzi, Omero Alessandro
Troncone, Edoardo
Monteleone, Giovanni
Dauri, Mario
Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
title Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
title_full Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
title_fullStr Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
title_full_unstemmed Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
title_short Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
title_sort feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401822/
https://www.ncbi.nlm.nih.gov/pubmed/37542218
http://dx.doi.org/10.1186/s12871-023-02218-6
work_keys_str_mv AT devicopasquale feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT biasuccidanieleg feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT aversanolucia feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT polidororoberto feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT zingaroalessia feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT millarellifrancescaromana feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT delvecchioblancogiovanna feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT paoluziomeroalessandro feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT tronconeedoardo feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT monteleonegiovanni feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy
AT daurimario feasibilityandsafetyofdeepsedationwithpropofolandremifentanilinspontaneousbreathingduringendoscopicretrogradecholangiopancreatographyanobservationalprospectivestudy